Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Industry News
Share your love
Mydriasis: Causes, Symptoms, Treatment | OBN
Mydriasis, a condition that leads to the dilation of the pupil, may seem like a simple phenomenon, but there’s more to it than meets the eye. Behind this seemingly straightforward occurrence lies a complex interplay of factors that can significantly…
What Is Corneal Neovascularization? | OBN
What is Corneal Neovascularization? Corneal neovascularization refers to the abnormal growth of blood vessels in the cornea, which is the clear, dome-shaped surface at the front of the eye. The cornea is responsible for protecting the eye and allowing light…
Posterior Capsular Opacification | OBN
What Is Post-Capsular Opacification? After a smooth sail through cataract surgery, post capsular opacification (PCO) can appear like a rogue wave, unexpected and potentially disruptive. It’s not an iceberg that sinks the ship, but it’s certainly worth keeping an eye…
OcuCell Partners with Georgia Eye Bank for Funding
OcuCell, a provider of ocular cell therapy, has announced funding from the Georgia Eye Bank. Established in 1961, the Georgia Eye Bank has contributed over 60,000 corneas for transplantation, demonstrating a commitment to enhancing vision and enriching lives through the…
Neurophth’s ADOA Candidate Drug Gets Australian Approval
Neurophth Therapeutics announced that the Australian Therapeutic Goods Administration (TGA) has granted registration and approval for its candidate drug, NFS-05, for clinical trials aimed at addressing autosomal dominant optic atrophy (ADOA). According to a company news release, ADOA is an…
Overview of Ptosis Surgery | OBN
Ptosis is when the upper eyelid droops over the eye. The eyelid may droop just a little, or so much that it covers the pupil (the black dot at the center of your eye that lets light in). Ptosis can…
Types of Custom Contact Lenses
Custom contact lenses are created especially for you and precisely fit your eyes. These are mainly applied when conventional contact lenses are irritating you and cause discomfort every time you use them. These are extremely convenient if you have astigmatism…
Bausch + Lomb Introduces Dry Eye Drug Miebo in the U.S.
Bausch + Lomb has officially launched Miebo (perfluorohexyloctane ophthalmic solution) for the treatment of dry eye disease (DED) in the United States. Earlier in May, Bausch + Lomb and Novaliq received FDA approval for Miebo, marking it as the first…
Alcon Introduces Launch Of AcrySof IQ Vivity
Development of active glasses for mitigating presbyopia has become an active area of research, facilitated by the miniaturization of focus-tunable lenses as well as the increased processing power of modern computers. Alcon the global leader in eye care dedicated to…
Ophthalmic Market Projected to Reach $532.8M by 2026
The global ophthalmic sutures market size is expected to reach USD 532.8 million by 2026, expanding at a CAGR of 6.4% over the forecast period, according to a new report by Grand View research, Inc. Key factors driving the market…